Showing results (411-420 of 533) with videos related to

Sort By:
Pageof 54
Scientific Reports|February 12, 2020
Author Correction: Circulating Levels of Inflammatory Proteins and Survival in Patients with Gallbladder CancerZhiwei Liu, Troy J Kemp, Yu-Tang Gao, et al.
Cancers|November 11, 2022
Association between Immunologic Markers and Cirrhosis in Individuals from a Prospective Chronic Hepatitis C CohortIlona Argirion, Jalen Brown, Sarah Jackson, et al.
The Journal of Infectious Diseases|August 12, 2025
Validation of TypeSeq2, a Next-Generation-Based Sequencing Assay for the Detection of 46 Human Papillomavirus Genotypes, at the US National Cancer Institute and Costa Rica LaboratoriesMónica S Sierra, Carolina Coto, Carolina Porras, et al.
British Journal of Cancer|October 2, 2003
Seroprevalence of human papillomavirus-16, -18, -31, and -45 in a population-based cohort of 10000 women in Costa RicaS S Wang, M Schiffman, T S Shields, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 23, 2015
Associations of Coffee Drinking with Systemic Immune and Inflammatory MarkersErikka Loftfield, Meredith S Shiels, Barry I Graubard, et al.
Cancer Research|April 1, 2010
A population-based prospective study of carcinogenic human papillomavirus variant lineages, viral persistence, and cervical neoplasiaMark Schiffman, Ana Cecilia Rodriguez, Zigui Chen, et al.
Journal of the National Cancer Institute|November 8, 2019
Efficacy of the AS04-Adjuvanted HPV16/18 Vaccine: Pooled Analysis of the Costa Rica Vaccine and PATRICIA Randomized Controlled TrialsJoseph E Tota, Frank Struyf, Joshua N Sampson, et al.
The Journal of Infectious Diseases|August 27, 2002
Comprehensive analysis of human leukocyte antigen class I alleles and cervical neoplasia in 3 epidemiologic studiesSophia S Wang, Allan Hildesheim, Xiaojiang Gao, et al.
The Lancet. Infectious Diseases|July 19, 2025
Human papillomavirus (HPV) type 16 and type 18 antibody concentrations after a single dose of bivalent HPV vaccine in girls aged 9-14 years compared with three doses of quadrivalent HPV vaccine in women aged 18-25 years in Costa Rica (PRIMAVERA): a non-randomised, open-label, immunobridging, non-inferiority trialBernal Cortés, Rebeca Ocampo, Carolina Porras, et al.
Communications Medicine|July 22, 2023
Behavioral factors and SARS-CoV-2 transmission heterogeneity within a household cohort in Costa RicaKaiyuan Sun, Viviana Loria, Amada Aparicio, et al.
Pageof 54